Company Profile:
Company Introduction: TRABIO CO. LTD.
Nature of Business: Factory (Research, Development, and Manufacturing)
TRABIO CO. LTD. is a South Korean biopharmaceutical company primarily engaged in the research, development, and potential manufacturing of novel therapeutics. The company focuses on innovative drug discovery platforms to address unmet medical needs, with a significant emphasis on ophthalmological diseases such as age-related macular degeneration (AMD). They also explore drug candidates for other therapeutic areas including oncology and central nervous system disorders.
TRABIO operates as an R&D and manufacturing entity, developing drug candidates from their initial discovery phases through preclinical and clinical trials. Their core expertise lies in utilizing advanced biotechnologies to identify, optimize, and ultimately produce new pharmaceutical products. This process positions them as a factory in the sense of creating and producing intellectual property and potentially physical drug substances or finished products. They are not a trading company.